Skip to: Content
Skip to: Site Navigation
Skip to: Search

October 12, 2008 7:48:46 PM CDT



FDA Warned of Avandia Risks Years Ago

Posted May 24, 07 1:56 PM CDT in Business Science & Health 

(Newser) – A diabetes doctor warned the FDA of heart risks posed by the diabetes drug Avandia seven years ago, the New York Times reports. The same concerns raised by Dr. John Buse in a 2000 letter were reiterated in a study published by cardiologist Steven Nissen this week.

Documents show that the FDA subsequently reprimanded the drug's maker, GlaxoSmithKline, for minimizing risks. In an interview with the Times, Dr. Buse sticks to his assessment of Avandia, but adds that there should not be a rush to pull it from the market until more studies are completed. “In the last several years, there has not been a study that’s made me feel better about this," he says.

Source New York Times

0 comments | Print E-mail | Digg Seed this on Newsvine Add this link to Del.icio.us StumbleUpon
This undated photo provided by the Cleveland Clinic shows the Cleveland Clinic's cardiology chief, Dr. Steven Nissen. Research by Dr. Nissen has helped keep four dangerous drugs out of the public's hands...   (Associated Press)
« Prev« Prev | Next »Next » Slideshow

Threads (
1
 of 4)

Tags

health   diabetes   GlaxoSmithKline   Avandia   pharma



Loading...

Premium Articles from HighBeam

Find more articles like this

Today's Most Popular

Loading...

Other Home Stories


What is Newser?

2008 Codie Finalist

Newser gives you more news in less time. We search for the best and most important stories all over the web, read them for you, and deliver concise and sharp summaries—along with links to the full text. Newser provides a way to stay on top of an ever-expanding horizon of news and opinion—politics, sports, business, trends, technology, personalities, crimes, and controversies. Newser keeps you not just better informed, but, with our signature graphic interface and smart condensed format, more enjoyably informed.

Learn more »